Scalper1 News
Two of the world’s biggest drugmakers issued a mixture of Q4 reports Friday in what continues to be a tough earnings season. AbbVie (ABBV) said profit excluding one-time items rose 8.5% over the year-earlier quarter to 89 cents, beating analysts’ consensus by 3 cents, according to Thomson Reuters. Sales climbed 5.1% to $5.37 billion, $11 million ahead of consensus. For the full year, profit increased 5.7% to $3.32 a share, with sales gaining 6.2% Scalper1 News
Scalper1 News